Q1 2020 13F Holders as of 31 Mar 2020
-
Type / Class
-
Equity / ISHARES BIOTECH
-
Total 13F shares
-
47,144,066
-
Share change
-
-6,566,128
-
Total reported value
-
$5,081,744,912
-
Put/Call ratio
-
203%
-
Price per share
-
$107.74
-
Number of holders
-
660
-
Value change
-
-$740,712,721
-
Number of buys
-
240
-
Number of sells
-
362
Institutional Holders of ISHARES TR - ISHARES BIOTECH (IBB) as of Q1 2020
As of 31 Mar 2020,
ISHARES TR - ISHARES BIOTECH (IBB) was held by
660 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
47,144,066 shares.
The largest 10 holders included
BANK OF AMERICA CORP /DE/, MORGAN STANLEY, GOLDMAN SACHS GROUP INC, BARCLAYS PLC, CITIGROUP INC, UBS Group AG, JPMORGAN CHASE & CO, BNP PARIBAS ARBITRAGE, SA, HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND, and ROYAL BANK OF CANADA.
This page lists
660
institutional shareholders reporting positions in this security
for the Q1 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.